Advertisement

Mechanism of Gonadotrophin Releasing Hormone Receptor Mediated Regulation of G-Proteins in Clonal Pituitary Gonadotrophs

  • Bukhtiar H. Shah
  • David J. Macewan
  • Graeme Milligan

Abstract

Guanine nucleotide binding proteins (G-proteins) function to transduce hormonal and sensory signals from plasma membrane receptors to effectors to regulate cellular functions. Binding of gonadotrophin releasing hormone (GnRH) receptor agonist to its receptor causes production of the second messengers inositiol-1,4,5-triphosphate (IP3) and sn-1,2-diacyglycerol (DAG) through the hydrolysis of phosphatidylinositol-4,5-bisphosphate because this receptor is coupled to Gq and G11 G-proteins. Prolonged exposure of αT3-1 pituitary gonadotrophs to a GnRH agonist results in marked downregulation of α-subunits of G/11. The agonist-mediated downregulation is concentration and time-dependent and is not altered by treatment of cells with protein kinase C (PKC) activators and inhibitors. However the turnover of G/G11α is substantially accelerated in the presence of agonist as revealed through 35S-labelled pulse chase experiments. By contrast the rate of degradation of the G-protein Gi2α is unaffected by agonist treatment. Analysis of G/G11α mRNA levels by reverse transcription/polymerase chain reaction (RT/PCR) demonstrated no differences between control and agonist-treated cells. These studies indicate that GnRH receptor agonist-mediated down regulation of G/G11α is independent of PKC and is a reflection of enhanced proteolysis of the activated G-proteins.

Keywords

GnRH Agonist Inositol Phosphate GnRH Analogue GnRH Receptor Guanine Nucleotide Binding Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eidne, K.A., Seller, R.E., Couper, G., Anderson, L. and Taylor, P.L. (1992) Mol. Cell. Endocrinol. 90: R5–R9.PubMedCrossRefGoogle Scholar
  2. 2.
    Tsutsumi, M., Zhou, W., Millar, R.P., Mellon, P.L., Roberts, J.L., Flanagan, C.A., Dong, K., Gillo, B. and Sealfon S.C. (1992) Mol. Endocrinology 6: 1163–1169.CrossRefGoogle Scholar
  3. 3.
    Windle, J.J., Weiner, R.I. and Mellon, P.L. (1990) Mol. Endocrinology 4: 597–603.CrossRefGoogle Scholar
  4. 4.
    Gilman, A.G., Rall, T.W., Nies, A.S. and Taylor, P. (1990) In: The Pharmacological Basis of Therapeutics. 8th Ed., pp: 1333–1360.Google Scholar
  5. 5.
    Anderson, L., Milligan, G. and Eidne, K.A. (1993) J. Endocrinol. 136: 51–58.PubMedCrossRefGoogle Scholar
  6. 6.
    Milligan, G. (1993) Trends Pharmacol. Sci. 14: 413–418.PubMedCrossRefGoogle Scholar
  7. 7.
    Milligan, G., Wise, A., MacEwan, D.J., Kennedy, F.R., Lee, T.W., Aide, E.J., Svoboda, P., Shah, B.H. and Mullaney, I. (1995) Biochem. Soc. Trans. 23: 166–170PubMedGoogle Scholar
  8. 8..
    Milligan, G., Shah, B.H., Mullaney, I. and Grassie, M. (1995) J. Recept. Res. 15: 253–263.Google Scholar
  9. 9.
    Hadcock, J.R., Port, J.D. and Malbon, C.C. (1991) J. Biol. Chem. 266: 11915–11922.PubMedGoogle Scholar
  10. 10.
    Hseih, K.P. and Martin, T.F.J. (1992) Mol. Endocrinology 6: 1673–1681.CrossRefGoogle Scholar
  11. 11.
    Shah, B.H. and Milligan, G. (1994) Mol. Pharmacology 46: 1–7.Google Scholar
  12. 12.
    Shah, B.H., MacEwan, D.J. and Milligan, G. (1995) Proc. Natl. Acad. Sci. USA (in press).Google Scholar
  13. 13.
    Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., (1951) J. Biol. Chem. 193: 265–275.PubMedGoogle Scholar
  14. 14.
    Mullaney, I, Dodd, M.W., Buckley, N. and Milligan, G. (1993) Biochem. J. 289: 125–131.PubMedGoogle Scholar
  15. 15.
    Mitchell, F.M., Buckley, N.J., and Milligan, G. (1993) Biochem. J. 293: 495–499.PubMedGoogle Scholar
  16. 16..
    McKenzie, F.R., and Milligan, G. (1.990)J Biol. Chem. 265: 17084–17093.Google Scholar
  17. 17.
    Chang, F.H. and Boume, H.R. (1989) J. Biol. Chem. 264: 5352–5337.PubMedGoogle Scholar
  18. 18.
    Shah, B.H. and Milligan, G. (1994) J. Neurochemistry 63: S32A.Google Scholar
  19. 19.
    Rapiejko, P.J., Watkins, D.C., Ros, M. and Malbon, C.C. (1989) J. Biol. Chem. 264: 16183–16189.PubMedGoogle Scholar
  20. 20.
    Paulssen, E.J., Paulssen, R.H., Haugen, T.B., Gautvik, K.M., and Gordeladze, J.O. (1991) Acta Physiol. Scand. 143: 195–201.PubMedCrossRefGoogle Scholar
  21. 21.
    Loganzo, F. Jr., Fletcher, P.W. (1993) Mol. Endocrinol. 7: 434–440.PubMedCrossRefGoogle Scholar
  22. 22.
    Mullaney, I., Shah, B.H., Wise, A. and Milligan, G. (1995) J. Neurochemistry (in press).Google Scholar
  23. 23.
    Levis, M.J. and Bourne, H.R. (1992) J. Cell Biol. 119: 1297–1307.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Bukhtiar H. Shah
    • 1
  • David J. Macewan
    • 2
  • Graeme Milligan
    • 2
  1. 1.Department of PhysiologyThe Aga Khan University Medical CollegeKarachiPakistan
  2. 2.Molecular Pharmacology Group Division of Biochemistry and Molecular Biology Institute Biomedical and Life SciencesUniversity of GlasgowGlasgowScotland, UK

Personalised recommendations